Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHAR 300 > Lec. 23 - Drug Design 2: Clinical Trials > Flashcards

Lec. 23 - Drug Design 2: Clinical Trials Flashcards

1
Q

Why do we need to do human trials even after animal models?

A

Due to

  • Human differences
  • Species variability
  • Differences in pharmacokinetics and pharmacodynamics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What part of drug development is most expensive?

A

Clinical trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 3 questions clinical trials aim to answer?

A

Is it safe?

Does it work?

Is there a better alternative already on the market?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 3 phases to clinical trials?

A

Phase 1: Human safety/Pharmacokinetics:
20-80 healthy volunteers

Phase 2: Evaluate effectiveness/Side Effects:
100-300 patient volunteers (who have illness)

Phase 3: Verify effectiveness/Long time use:
1000-3000 patient volunteers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe clinical trials - phase 1

  • Goal
  • Population
  • Duration
  • Process
A

Goal:
Test human safety

Population:
20-80 healthy people, monitored carefully

Duration:
Days or weeks

Process:
-Starts with pharmacokinetics monitoring.
-If safe, expands to safety testing
(starting at low doses until therapeutic dose reached)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe clinical trials - phase 2

  • Goal
  • Population
  • Duration
  • Process
A

Goal:

  • Test if drug works
  • Evaluate side effects

Population:
100-300 patients with disorder

Duration:
Weeks or months

Process:

  • Check for pain in patients
  • Expand pharmacokinetics knowledge to range (poor metabolizers, poor responders)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe clinical trials - phase 3

  • Goal
  • Population
  • Duration
  • Process
A

Goal:

  • Verify efficacy
  • Study long term effects

Population:
1000-3000 patients

Duration:
Several years

Process:

  • Verify adverse effects in long term use
  • Find even rarer side effects (larger pool of participants)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain 2 methods of clinical trial

A

Parallel design:

  • To test vs drug on the market
  • Have two concurrent groups testing new drug vs one on market

Crossover design:

  • 2 concurrent groups testing both market and new drug
  • Market (washout) then new
  • New (washout) then market
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name and explain 2 things to control for

A

Lifestyle:

  • Important effect on patient well being
  • Ex. have 4 groups for diabetes experiment (placebo vs. new drug vs. market drug vs. intense lifestyle change)

Patient Compliance:
-Mortality hin people will less than 80% complicance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why do short term drugs still need to be monitored in long term?

A

See if the treatment is consistent (ex. is there an ulcer relapse)

ex. lorezepam (benzodiazepine) ‘pain relief’ effects wear off after a few weeks (as what was being felt was sedation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What good study demonstrated the placebo response?

A

Doctor coming in with treatment vs machine administering hidden treatment.

Doctor yielded higher pharmacological response due to expectancy related effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe an example of behavioural conditioning

A

Pill on its own -> brain activity

Pill + neutral stimulus -> brain activity (acquisition)
Neutral stimulus (after conditioning) -> brain activity (evocation)

Conditioned response to neutral stimulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give an example of drug resistance being something to watch for in clinical trials

A

If your drug for a tumor were only somewhat effective, you could end up with a drug that whittles a tumour down to a few, drug-resistant cells that could then come back stronger.

It is important to monitor long term to ensure tumor resistance doesn’t occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What needs to be done after phase III of a clinical trial?

A

Data needs to be evaluated for efficacy and safety (NDA, health Canada, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name 4 ways NDA reviews information from clinical trials

A
  • Characterize exposure database (check that random assignments occurred)
  • Identify adverse effects
  • Estimate risk of side effects
  • Identify risk factors (ie patient characteristics)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are orphan drugs? How are they funded?

A

Orphan drugs are made for specific diseases affecting a small number of people, so not much profit to be made.

Usually funded by governments

17
Q

What is main reason for drug failure in clinical trials?

A

Pathogenesis of treatment clearly was incorrect! Drugs did not really target problem

18
Q

What are 3 important factors for a drug going into market

A

Needs to be:

  • cheap
  • stable (no disintegrating on shelf)
  • Soluble (ideally absorbed in pill. If not, injection)
19
Q

What’s a possible solution to short half-life of drug?

A

Design a slow-release pill to take everyday

20
Q

What is clinical phase 4?

A

Released to public, but continuously monitored for safety and efficacy.

INCREDIBLY uncommon side-effects can be found (since drug is being put out to millions of people)

Uncommon adverse drug reactions (ADR) can be observed (since 1/1000 reaction would need 3000 cases to have a 95% chance of observing it

21
Q

What demographic is particularly observed during phase IV?

A

Elderly and young (as they are usually omitted from clinical trials)

22
Q

What happens to a drug if there are serious risks, but still has therapeutic benefits?

A

Black box warning -> UTMOST caution must be used when taking drugs

23
Q

What are the 3 classes of clinical trials?

A

Class3:
Normal

Class2:
Faster (ex. life-threatening diseases)

Class1:
Even faster (emergencies)
24
Q

Describe a success of MAB therapy in 2018.

A

Pembrolizumab won the nobel prize for immunotherapy against cancer.

Tumor cells can often utilize checkpoint proteins to inhibit T-cells (ex. PDL1 binds at PD1 receptor)

Pembrolizumab targets PD1, allowing T-cells to kill cancer.

25
Q

Give an example of a drug successfully treating cancer

A

Ibrutinib treats chronic lymphocytic leukemia

Targets btk enzyme, which allows malignant B-cells to overly express.

Thus, ibrutinib blocks B-cell proliferation

26
Q

What other functions can MAbs have to combat cancer?

A
  • Deliver radioisotope to tumor cells
  • Block Growth Factor receptors on tumor cells
  • Used to identify tumor cells and give a more accurate prognosis
27
Q

MAB implications for migraines?

A

Calcitonin-gene related peptide (CGRP) often implicated in migraines.

Mabs can be injected once a month to block CGRP and prevent migraines.

28
Q

What treats Hep. C

A

Sofosbuvir

29
Q

What drugs can help heart failure?

A

Heart is too weak and can’t pump blood

Natriurietic and vasoactive peptides usually lower BP, but they are broken down too fast by neprilysin

New drug targets neprilysin

PHAR 300 (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions